BMRN
NASDAQ · Biotechnology
Biomarin Pharmaceutical Inc
$55.90
+1.21 (+2.21%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-6.76%
1Y
+3.37%
YTD
-5.97%
Open$55.51
Previous Close$54.69
Day High$56.31
Day Low$54.96
52W High$66.28
52W Low$49.26
Volume—
Avg Volume2.00M
Market Cap10.57B
P/E Ratio39.33
EPS$1.35
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$57.48
Below
SMA 200
$56.51
Below
RSI (14)
80.7
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
34 analysts
Price Target
+126.2% upside
Current
$55.90
$55.90
Target
$126.44
$126.44
$89.21
$126.44 avg
$194.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.15B | 2.73B | 1.41B |
| Net Income | 341.63M | 266.44M | -2,303,166 |
| Profit Margin | 10.8% | 10.3% | -0.2% |
| EBITDA | 419.93M | 345.70M | -4,073,088 |
| Free Cash Flow | — | — | -1,983,877 |
| Rev Growth | +15.4% | +15.4% | -7.9% |
| Debt/Equity | 0.10 | 0.10 | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |